Nigericin is a potent inhibitor of the early stage of vaccinia virus replication. (Record no. 20255009)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01538 a2200421 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250516005046.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201102s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1872-9096 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1016/j.antiviral.2010.10.001 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Myskiw, Chad |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20110228 |
245 00 - TITLE STATEMENT | |
Title | Nigericin is a potent inhibitor of the early stage of vaccinia virus replication. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Antiviral research |
Date of publication, distribution, etc. | Dec 2010 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 304-10 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antiviral Agents |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Bioterrorism |
General subdivision | prevention & control |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Carboxylic Acids |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Gene Expression Regulation, Viral |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Green Fluorescent Proteins |
General subdivision | analysis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | HeLa Cells |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Inhibitory Concentration 50 |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Nigericin |
General subdivision | analogs & derivatives |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Poxviridae Infections |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Time Factors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Transcription, Genetic |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Vaccinia virus |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Virus Replication |
General subdivision | drug effects |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Piper, Jessica |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Huzarewich, Rhiannon |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Booth, Tim F |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cao, Jingxin |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | He, Runtao |
773 0# - HOST ITEM ENTRY | |
Title | Antiviral research |
Related parts | vol. 88 |
-- | no. 3 |
-- | p. 304-10 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1016/j.antiviral.2010.10.001">https://doi.org/10.1016/j.antiviral.2010.10.001</a> |
Public note | Available from publisher's website |
No items available.